While GSK, AstraZeneca and Eli Lilly have hit the headlines in the
UK Serious Fraud Office's (SFO) investigation into illegal bribes
paid to Saddam Hussein's Iraqi regime, many more pharma firms are
on the organisation's...
Chemical companies Solvay and Akzo Nobel have coughed up $72.8m
(€59.7m) to settle a lawsuit from the US Justice Department while
having to plead guilty of fixing prices for sodium perborate, an
oxidising agent used mainly in detergents,...
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported
third-quarter sales of €3,29 billion, a slight decrease from the
previous quarter but up 5.4 per cent from the comparable period in
2004, thanks to growth in all its units,...
Dutch pharmaceutical and chemicals group Akzo Nobel topped
analysts' estimates with its first-quarter results, with
indications that its pharmaceutical unit has turned the corner
after a difficult 2004, reports Phil Taylor.
Three chemicals companies - Akzo Nobel, the Hoechst unit of
Sanofi-Aventis and Total subsidiary Arkema - have been fined €217
million by the European Commission for operating a cartel in the
market for monochloroacetic acid (MCAA).
Dutch chemicals and drugs group Akzo Nobel saw its net income
accelerate in the third quarter of this year, to the surprise of
analysts and investors, and helped by cost reductions and a big
gain from the divestment of its coatings...
The chief executive of Akzo Nobel expects to record sales of more
than $1 billion in China within the next five years, more than
double the level at present, and is boosting its presence in the
country in anticipation.
Akzo Nobel has unveiled a plan to 'fix' its troubled
pharmaceuticals businesses, hit by patent expirations, safety
concerns with some core product lines and a difficult operating
environment for contract manufacturing of...
Dutch pharmaceuticals and chemicals group Akzo Nobel has reported a
small decline in sales in the first half of the year, although the
cost of ongoing restructuring caused net earnings to slump by
nearly a quarter to €245 million.
The Netherlands-based pharmaceuticals, coatings and chemicals firm
Akzo Nobel has posted a 7 per cent rise in net income to €176
million for the first quarter of 2004, a little more than expected,
but has warned that its pharmaceuticals...
Dutch chemical company Akzo Nobel followed through on its plans to
cut costs at its pressured Diosynth subsidiary by slashing staff at
the unit, which has been hit by a deteriorating market for its
manufacturing services in both chemical...
Pharmaceutical, chemical and coatings company Akzo Nobel reported a
9 per cent slide in net income in 2003 but said the result was
better than expected given the difficult operating environment last